Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Aadi Bioscience, Inc. on June 14, 2022. The filing details the voting results for director elections and the ratification of the independent auditor. The record date for the meeting was April 20, 2022.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document serves to disclose the outcomes of shareholder votes regarding corporate governance.
Outlook, Risks, and Management Commentary
Management commentary is limited to the reporting of voting results. No specific guidance, outlook, risks, or contingencies are detailed in this text. The filing confirms the appointment of BDO USA LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
Important Facts for Investors
- Quorum Achieved: 15,099,527 shares were present, representing approximately 72% of the voting power.
- Director Election Results:
- Anupam Dalal: 11,291,829 votes For; 454,197 votes Withheld.
- Karin Hehenberger: 11,726,212 votes For; 19,814 votes Withheld.
- Auditor Ratification: BDO USA LLP was ratified with 15,019,683 votes For, 66,252 votes Against, and 13,592 Abstentions.
- Company Status: The registrant is an emerging growth company.